Peter Hecht
Direktor/Vorstandsmitglied bei CYCLERION THERAPEUTICS, INC.
Vermögen: 1 Mio $ am 30.04.2024
Profil
Peter M.
Hecht was the founder of Ironwood Pharmaceuticals, Inc. (founded in 1998) where he held the title of Chief Executive Officer & Director from 1998 to 2019.
He is also the founder of Cyclerion Therapeutics, Inc. (founded in 2019) where he currently holds the title of Director.
In his current roles, Dr. Hecht is the Chief Executive Officer of Tisento Therapeutics, Inc. and a Director at Kallyope, Inc. (since 2020) and Mythic Therapeutics, Inc. Dr. Hecht has previously worked as a Director at Microbia, Inc. and the Whitehead Institute for Biomedical Research.
He obtained his undergraduate and graduate degrees from Stanford University and holds a doctorate degree from the University of California, Berkeley.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
CYCLERION THERAPEUTICS,INC.
13,93% | 17.04.2024 | 377 385 ( 13,93% ) | 1 Mio $ | 30.04.2024 |
Aktive Positionen von Peter Hecht
| Unternehmen | Position | Beginn |
|---|---|---|
| CYCLERION THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 01.04.2019 |
Kallyope, Inc.
 Kallyope, Inc. Medical/Nursing ServicesHealth Services Kallyope, Inc. engages in developing drugs and consumer products. Its specialties include biotechnology, gut-brain axis, nutrition, and pharmaceuticals. The company was founded by Thomas P. Maniatis, Charles Zuker and Richard Axel in 2014 and is headquartered in New York, NY. | Direktor/Vorstandsmitglied | 20.02.2020 |
Mythic Therapeutics, Inc.
 Mythic Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mythic Therapeutics, Inc. engages in the development of cancer therapeutics. The company was founded on June 6, 2018 and is headquartered in Waltham, MA. | Direktor/Vorstandsmitglied | - |
Tisento Therapeutics, Inc.
 Tisento Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Tisento Therapeutics, Inc. develops medicines to treat diseases. The CEO of the American company is Peter M. Hecht. | Vorstandsvorsitzender | - |
Ehemalige bekannte Positionen von Peter Hecht
| Unternehmen | Position | Ende |
|---|---|---|
| IRONWOOD PHARMACEUTICALS, INC. | Gründer | 01.04.2019 |
Whitehead Institute for Biomedical Research
 Whitehead Institute for Biomedical Research Miscellaneous Commercial ServicesCommercial Services Whitehead Institute for Biomedical Research provides research and technology services. Its services include biomedical, genomics, and genetics for students. The company was founded by Edwin C. Whitehead in 1982 and is headquartered in Cambridge, MA. | Direktor/Vorstandsmitglied | - |
Microbia, Inc.
 Microbia, Inc. Pharmaceuticals: MajorHealth Technology Microbia, Inc. engages in the development of microbial manufacturing technologies for the production of chemicals from renewable raw materials. The company is headquartered in DE. | Direktor/Vorstandsmitglied | - |
Ausbildung von Peter Hecht
| Stanford University | Graduate Degree |
| University of California, Berkeley | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| IRONWOOD PHARMACEUTICALS, INC. | Health Technology |
| CYCLERION THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 5 |
|---|---|
Microbia, Inc.
Microbia, Inc. Pharmaceuticals: MajorHealth Technology Microbia, Inc. engages in the development of microbial manufacturing technologies for the production of chemicals from renewable raw materials. The company is headquartered in DE. | Health Technology |
Whitehead Institute for Biomedical Research
Whitehead Institute for Biomedical Research Miscellaneous Commercial ServicesCommercial Services Whitehead Institute for Biomedical Research provides research and technology services. Its services include biomedical, genomics, and genetics for students. The company was founded by Edwin C. Whitehead in 1982 and is headquartered in Cambridge, MA. | Commercial Services |
Kallyope, Inc.
Kallyope, Inc. Medical/Nursing ServicesHealth Services Kallyope, Inc. engages in developing drugs and consumer products. Its specialties include biotechnology, gut-brain axis, nutrition, and pharmaceuticals. The company was founded by Thomas P. Maniatis, Charles Zuker and Richard Axel in 2014 and is headquartered in New York, NY. | Health Services |
Mythic Therapeutics, Inc.
Mythic Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mythic Therapeutics, Inc. engages in the development of cancer therapeutics. The company was founded on June 6, 2018 and is headquartered in Waltham, MA. | Health Technology |
Tisento Therapeutics, Inc.
Tisento Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Tisento Therapeutics, Inc. develops medicines to treat diseases. The CEO of the American company is Peter M. Hecht. | Health Technology |
